-
In this issue: Statins and diabetes risk; new treatment guideline for diabetes; new pertussis vaccine recommendation; antibiotics and rhinosinusitis; fluoroquinolones and cystitis; and FDA actions.
-
Hong Kong investigators conducted 2 separate community studies using careful face-to-face instructions to potentially influenza infected patients. Sterile nasal swabs were rotated around the anterior nares.
-
Dealing with cytomegalovirus (CMV) can be vexing for everybody involved, but a recent paper may help with the management and counseling of patients infected with this virus at different times before and during pregnancy.
-
A Centers for Medicare & Medicaid Services draft infection control survey expected to be finalized for use in hospitals next year could lead to increased support and appreciation for the challenges faced by central services departments, says Rose Seavey, RN, BS, MBA, CNOR, CRCST, CSPDT, President/CEO of Seavey Healthcare Consulting, Inc., in Arvada, CO.
-
The Centers for Disease Control and Prevention is trying to overcome some stubborn myths and misperceptions about single-dose vials including the following, which the agency refuted with the current facts.
-
In what is getting to be a familiar, tragic refrain, the improper use of single-dose vials recently resulted in patients at pain clinics in Arizona and Delaware acquiring serious bacterial infections that were "completely preventable," the Centers for Disease Control and Prevention reports.
-
In light of recurrent outbreaks linked to misuse of single-dose medication vials, the Centers for Disease Control and Prevention is emphasizing that medications labeled as "single dose" or "single use" are to be used for only one patient.
-
Looking for a quality improvement (QI) project targeting catheter-associated urinary tract infections (CAUTIs)? Here's one that produced dramatic results, including a 68% decline in the CAUTI rate and a 20% reduction in the use of indwelling urinary catheters.
-
This study was a secondary analysis of data from an earlier randomized clinical trial comparing one antibiotic vs two (meropenem alone or meropenem plus ciprofloxacin) as early empiric therapy for ventilator-associated pneumonia (VAP).
-